These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 6437352)
1. Progressive augmentation of locomotor activity in mice by long-term treatment with thyrotropin releasing hormone. Ushijima I; Yamada K; Noda Y; Furukawa T Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):29-37. PubMed ID: 6437352 [TBL] [Abstract][Full Text] [Related]
2. Effects of acute and long-term treatments with thyrotropin-releasing hormone on locomotor activity and jumping behavior in mice. Ushijima I; Mizuki Y; Hara T; Watanabe K; Hirano H; Yamada M; Glavin GB Pharmacol Biochem Behav; 1986 May; 24(5):1423-8. PubMed ID: 3088609 [TBL] [Abstract][Full Text] [Related]
3. Behavioral effects of lithium on presynaptic sites of catecholaminergic neurons in the mouse. Ushijima I; Yamada K; Furukawa T Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):58-67. PubMed ID: 3094470 [TBL] [Abstract][Full Text] [Related]
4. Biphasic effects of thyrotropin-releasing hormone on exploratory behavior in mice. Ushijima I; Yamada K; Furukawa T; Noda Y; Todoroki M; Inanaga K Arch Int Pharmacodyn Ther; 1980 Oct; 247(2):257-63. PubMed ID: 6778401 [TBL] [Abstract][Full Text] [Related]
5. Jumping behavior induced by thyrotropin releasing hormone in combination with apomorphine in mice. Ushijima I; Yamada K; Noda Y; Furukawa T Psychopharmacology (Berl); 1982; 76(1):1-4. PubMed ID: 6281836 [TBL] [Abstract][Full Text] [Related]
6. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning. Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991 [TBL] [Abstract][Full Text] [Related]
7. Modification of dopaminergic transmission by thyrotropin-releasing hormone. Narumi S; Nagawa Y Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147 [TBL] [Abstract][Full Text] [Related]
9. Effect of thyrotropin-releasing hormone on the locomotor and sensitizing effects of cocaine in rats. Przegaliński E; Papla I; Czepiel K; Wydra K; Nowak E; Lasoń W; Filip M Neuropeptides; 2004 Feb; 38(1):48-54. PubMed ID: 15003716 [TBL] [Abstract][Full Text] [Related]
10. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats. Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129 [TBL] [Abstract][Full Text] [Related]
11. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats. Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433 [TBL] [Abstract][Full Text] [Related]
12. Acute and long-term effects of thyrotropin releasing hormone on behavior mediated by dopaminergic and cholinergic activities in mice. Ushijima I; Yamada K; Furukawa T Psychopharmacology (Berl); 1984; 82(4):301-5. PubMed ID: 6427818 [TBL] [Abstract][Full Text] [Related]
13. Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice. Fredriksson A; Eriksson P; Archer T J Neural Transm (Vienna); 2006 Feb; 113(2):137-50. PubMed ID: 16082515 [TBL] [Abstract][Full Text] [Related]
14. Augmentation of sensitivity to ambulation-increasing effect of apomorphine induced by repeated administration in mice. Kuribara H; Tadokoro S Yakubutsu Seishin Kodo; 1984 Sep; 4(2):181-90. PubMed ID: 6543079 [TBL] [Abstract][Full Text] [Related]
15. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions. Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): Involvement of the DA system in the locomotor stimulating action of TA-0910. Yamamura M; Kinoshita K; Nakagawa H; Ishida R Jpn J Pharmacol; 1991 Jan; 55(1):57-68. PubMed ID: 1904114 [TBL] [Abstract][Full Text] [Related]